IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action

Autor: Lecour, Sandrine, Andreadou, Ioanna, Bøtker, Hans Erik, Davidson, Sean M., Heusch, Gerd, Ruiz-Meana, Marisol, Schulz, Rainer, Zuurbier, Coert J., Ferdinandy, Péter, Hausenloy, Derek J., Adamovski, Pavle, Batirel, Saime, Barteková, Monika, Bertrand, Luc, Beauloye, Christophe, Biedermann, David, Borutaite, Vilmante, Chlopicki, Stefan, Dambrova, Maija, Devaux, Yvan, Di Lisa, Fabio, Djuric, Dragan, Erlinge, David, Falcao-Pires, Ines, Galatou, Eleftheria, Garcia-Sosa, Alfonso, Girao, Henrique, Giricz, Zoltan, Gyongyosi, Mariann, Healy, Donagh, Jakovljevic, Vladimir, Jovanic, Jelena, Kararigas, George, Kerkal, Risto, Kolar, Frantisek, Kwak, Brenda, Leszek, Przemysław, Liepinsh, Edgars, Lonborg, Jacob, Longnus, Sarah, Marinovic, Jasna, Muntean, Danina Mirela, Nezic, Lana, Ovize, Michel, Pagliaro, Pasquale, Da Costa Gomes, Clarissa Pedrosa, Pernow, John, Persidis, Andreas, Pischke, Søren Erik, Podesser, Bruno, Potočnjak, Ines, Prunier, Fabrice, Ravingerova, Tanya, Serban, Alina, Slagsvold, Katrine, van Royen, Niels, Turan, Belma, Vendelin, Marko, Walsh, Stewart, Zidar, Nace, Yellon, Derek

Publikováno v: Basic Research in Cardiology, 116, 1
Basic Research in Cardiology
Lecour, S, Andreadou, I, Bøtker, H E, Davidson, S M, Heusch, G, Ruiz-Meana, M, Schulz, R, Zuurbier, C J, Ferdinandy, P, Hausenloy, D J & on behalf of the European Union-CARDIOPROTECTION COST ACTION CA16225 2021, ' IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria : guidelines of the EU-CARDIOPROTECTION COST Action ', Basic Research in Cardiology, vol. 116, no. 1, 52 . https://doi.org/10.1007/s00395-021-00893-5
Scientia
Lecour, Sandrine; Andreadou, Ioanna; Bøtker, Hans Erik; Davidson, Sean M; Heusch, Gerd; Ruiz-Meana, Marisol; Schulz, Rainer; Zuurbier, Coert J; Ferdinandy, Péter; Hausenloy, Derek J (2021). IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action. Basic research in cardiology, 116(1), p. 52. Springer 10.1007/s00395-021-00893-5
Basic Research in Cardiology, 116

Cardioprotection; Drug development; Infarction Cardioprotección; Desarrollo de fármacos; Infarto Cardioprotecció; Desenvolupament de fàrmacs; Infart Acute myocardial infarction (AMI) and the heart failure (HF) which may follow are among the leadi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b3dc6cad606a31805579961be9acf65
https://repository.ubn.ru.nl/handle/2066/239037

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.